subject: UNII:KX1N4TV7UY


subject: UMLS:C5226842

object_name: atrial fibrillation

tested_intervention: yes


subject: DRUGBANK:DB15807

subject_name: BBIBP-CorV


subject: DRUGBANK:DB15807

object_name: Vaccine adverse reaction


subject: UMLS:C2002939

object_name: Solid Neoplasm

tested_intervention: unsure


subject: PUBCHEM.COMPOUND:607

subject_name: Adderall

object_name: Harmful pattern of substance use


subject: PUBCHEM.COMPOUND:607

object_name: substance abuse


subject: PUBCHEM.COMPOUND:607

object_name: conduct disorder


subject: PUBCHEM.COMPOUND:607

object_name: attention deficit hyperactivity disorder, inattentive type


subject: UMLS:C0963149

subject_name: Definity

object_name: renal carcinoma


subject: UMLS:C0963149

object_name: kidney neoplasm


subject: UMLS:C0963149

object_name: kidney cancer


subject: CHEBI:31980

subject_name: Perflutren


subject: CHEBI:31980


subject: CHEBI:31980


subject: CHEBI:52993

subject_name: Lormetazepam

object_name: delirium


subject: CHEBI:52993

object_name: Delirium, CTCAE


subject: CHEBI:52993

object_name: Locally Advanced Malignant Neoplasm


subject: CHEBI:52993

object_name: Recurrent Malignant Neoplasm


subject: CHEBI:52993

object_name: Embolism, Tumor


subject: CHEBI:6539

subject_name: Lorazepam


subject: CHEBI:6539


subject: CHEBI:6539


subject: CHEBI:6539


subject: CHEBI:6539


subject: UNII:BK459F050X

object_name: unspecified adult solid tumor, protocol specific


subject: UMLS:C4287766

object_name: Neoplasm of cecum and/or colon and/or rectum


subject: UMLS:C4287766

object_name: colorectal neoplasm


subject: CHEBI:184472

subject_name: Nitrofurantoin

object_name: bacterial urinary tract infection


subject: CHEBI:184472

object_name: Urinary Tract Infection, CTCAE


subject: CHEBI:28793

subject_name: beta-D-glucan

object_name: Breastfeeding (mother)


subject: DRUGBANK:DB19271

subject_name: Yeast beta-D-glucan


subject: UMLS:C4316638

subject_name: Vaginal moisturizer cream

object_name: pelvic organ prolapse


subject: UMLS:C4316638

object_name: Hyperplasia of the endometrium


subject: UMLS:C4316638

object_name: postmenopausal atrophic vaginitis


subject: CHEBI:6916

subject_name: Mexiletine

object_name: Charcot-Marie-Tooth disease


subject: CHEBI:172786

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:172786

object_name: metabolic syndrome X


subject: CHEBI:4775

subject_name: Ellagic acid


subject: CHEBI:4775


subject: DRUGBANK:DB14317

subject_name: Pomegranate


subject: DRUGBANK:DB14317


subject: UMLS:C1961993

subject_name: pomegranate extract


subject: UMLS:C1961993


subject: CHEBI:3756

subject_name: Clonazepam

object_name: Seizure cluster


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Caffeine-related disorder


subject: CHEBI:73604

object_name: Newborn Encounter Admission Source


subject: CHEBI:73604

object_name: Newborn (finding)


subject: CHEBI:73604

object_name: Apnea in newborn


subject: UMLS:C5205491

subject_name: Anti-CD137 Agonistic Monoclonal Antibody ADG106

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5205491

object_name: Her2-receptor negative breast cancer


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: severe acute respiratory syndrome


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: intrahepatic cholangiocarcinoma


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: PUBCHEM.COMPOUND:147740

subject_name: Yasmin

object_name: adenomyosis


subject: UMLS:C0939533


subject: CHEBI:51799

subject_name: Imipenem

object_name: Sepsis


subject: CHEBI:51799

object_name: Sepsis, CTCAE


subject: CHEBI:190509


subject: CHEBI:190509


subject: CHEBI:91950


subject: CHEBI:91950


subject: CHEBI:3697

subject_name: Cilastatin


subject: CHEBI:3697


subject: PUBCHEM.COMPOUND:56971685

subject_name: Relebactam


subject: PUBCHEM.COMPOUND:56971685


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: Burn shock


subject: CHEBI:2704

subject_name: Anastrozole

object_name: Stage IB Breast Cancer AJCC v7


subject: CHEBI:2704

object_name: Stage IA Breast Cancer AJCC v7


subject: CHEBI:2704

object_name: stage IA breast cancer


subject: CHEBI:2704

object_name: Musculoskeletal Complication


subject: CHEBI:42797

subject_name: Gabapentin

object_name: Irritability, CTCAE


subject: CHEBI:42797

object_name: neuralgia


subject: CHEBI:42797

object_name: Neuropathic pain


subject: UMLS:C5828908

object_name: alcohol abuse


subject: UMLS:C5828908

object_name: alcohol dependence


subject: UMLS:C0770694

subject_name: trivalent influenza vaccine

object_name: mumps


subject: MESH:D007252

subject_name: Influenza Vaccines


subject: UMLS:C5395271

subject_name: Vaccine product containing only Influenza virus antigen (medicinal product)


subject: UMLS:C4287651

subject_name: Quadrivalent Inactivated Influenza Vaccine


subject: MESH:D009108

subject_name: Mumps Vaccine

object_name: influenza


subject: UMLS:C5240005

subject_name: Vaccine product containing only Mumps orthorubulavirus antigen (medicinal product)


subject: CHEBI:27241

subject_name: methyl uridin-5-yloxyacetate


subject: CHEBI:27241


subject: CHEBI:73616

subject_name: Met-Val


subject: CHEBI:73616


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: Compensated cirrhosis


subject: CHEBI:85078

object_name: Decompensated cirrhosis of liver


subject: CHEBI:3921

subject_name: Cromakalim

object_name: Post-Traumatic Headache


subject: CHEBI:6436

subject_name: Levcromakalim


subject: UMLS:C0244960


subject: CHEBI:2955

subject_name: Azithromycin

object_name: acute respiratory distress syndrome


subject: CHEBI:2955

object_name: adult acute respiratory distress syndrome


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: Recurrence


subject: CHEBI:44185

subject_name: Methotrexate


subject: UniProtKB:P47802

subject_name: MTX1_MOUSE Metaxin-1 (sprot)


subject: PR:000010755


subject: PUBCHEM.COMPOUND:157010100

subject_name: Potassium citrate

object_name: metabolic acidosis


subject: PUBCHEM.COMPOUND:157010100

object_name: bone disorder


subject: UMLS:C0796638

subject_name: Lurtotecan Liposome

object_name: ovarian cancer


subject: UMLS:C0796638

object_name: ovarian neoplasm


subject: UMLS:C0796638

object_name: ovarian carcinoma


subject: UMLS:C0796638

object_name: fallopian tube carcinoma


subject: UMLS:C0796638

object_name: fallopian tube cancer


subject: UMLS:C0796638

object_name: peritoneum cancer


subject: UNII:NY0COC51FI

subject_name: Tradipitant

object_name: Nonulcer dyspepsia


subject: CHEBI:167997

subject_name: Cellulose, microcrystalline

object_name: Safety Issues


subject: CHEBI:62968

subject_name: Microcrystalline cellulose


subject: CHEBI:453011

subject_name: Ciclopirox

object_name: vulva cancer


subject: CHEBI:453011

object_name: vulva carcinoma


subject: UMLS:C4049152

subject_name: doxycycline 100 MG Oral Tablet includes hyclate & monohydrate salts

object_name: traumatic encephalopathy


subject: UMLS:C4049152

object_name: traumatic brain injury


subject: UMLS:C4552106

subject_name: Product containing only doxycycline 100 mg/1 each oral tablet


subject: UMLS:C4552106


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:54671203


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: gastroesophageal adenocarcinoma


subject: UNII:DPT0O3T46P

object_name: ulcerative colitis


subject: UNII:DPT0O3T46P

object_name: inflammatory bowel disease 1


subject: CHEBI:6887

subject_name: Methylphenidate

object_name: Asthenia


subject: MESH:C000851

subject_name: flupentixol, melitracen drug combination

object_name: Heartburn


subject: MESH:C000851

object_name: Gastroesophageal Reflux Disease, CTCAE


subject: CHEBI:173687

subject_name: N,O-Didesmethyltramadol

object_name: Acute Ischemic Stroke


subject: CHEBI:173687

object_name: Ischemic stroke


subject: UMLS:C1550079

subject_name: M5 Additive/Preservative


subject: UMLS:C1550079


subject: UniProtKB:P07389

subject_name: VP5_BTV10 Outer capsid protein VP5 (sprot)


subject: UniProtKB:P07389


subject: CHEBI:3561

subject_name: Cetirizine

object_name: Altitude Hypoxia


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: psoriatic arthritis


subject: CHEBI:9667

subject_name: Triamcinolone


subject: UMLS:C0730970

subject_name: Creon 25000

object_name: steatorrhea


subject: CHEBI:8427

subject_name: Probucol

object_name: inborn mitochondrial metabolism disorder


subject: CHEBI:8427

object_name: mitochondrial disease


subject: CHEBI:8427

object_name: chronic kidney disease


subject: CHEBI:8427

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:94463

object_name: enterovirus infectious disease


subject: CHEBI:63580

subject_name: Ribavirin


subject: CHEBI:2948

subject_name: Azathioprine

object_name: IgA vasculitis


subject: CHEBI:2948

object_name: Primary cutaneous vasculitis


subject: CHEBI:2948

object_name: cutaneous polyarteritis nodosa


subject: CHEBI:23359

subject_name: colchicine


subject: CHEBI:23359


subject: CHEBI:23359


subject: CHEBI:4325

subject_name: Dapsone


subject: CHEBI:4325


subject: CHEBI:4325


subject: UNII:19J3781LPM

subject_name: Itacitinib

object_name: rheumatoid arthritis


subject: UMLS:C5142964

subject_name: Satin

object_name: Hypercholesterolemia


subject: UMLS:C5142964

object_name: inherited lipid metabolism disorder


subject: UMLS:C5142964

object_name: Dyslipidemia


subject: CHEBI:135010

subject_name: Enoximone

object_name: coronary artery disorder


subject: CHEBI:135010

object_name: coronary atherosclerosis


subject: CHEBI:194548

subject_name: Racepinephrine

object_name: No-Reflow Phenomenon


subject: CHEBI:9720

subject_name: Trihexyphenidyl

object_name: Cerebral Palsy, Dystonic-Rigid


subject: CHEBI:9720

object_name: athetoid cerebral palsy


subject: CHEBI:9720

object_name: Trihexyphenidyl adverse reaction


subject: CHEBI:9720

object_name: Pharmacogenomic drug interaction


subject: CHEBI:9720

object_name: Pediatric Disorder


subject: CHEBI:9720

object_name: Dystonia, Secondary


subject: CHEBI:9720

object_name: inherited disease susceptibility


subject: CHEBI:33942

subject_name: ribose

object_name: fibromyalgia


subject: CHEBI:47013

subject_name: D-ribofuranose


subject: CHEBI:16988

subject_name: D-ribose


subject: CHEBI:66910

subject_name: Axitinib

object_name: Renal cancer metastatic


subject: UMLS:C4329337

subject_name: TAB 001


subject: UMLS:C5201260


subject: UMLS:C5201260

object_name: Inflammation


subject: UMLS:C4519110

subject_name: Fletikumab

object_name: rheumatoid arthritis


subject: UMLS:C4519110


subject: CHEBI:16382

subject_name: Iodide

object_name: Parkinsonism


subject: CHEBI:16382

object_name: Kinetic tremor


subject: CHEBI:16382

object_name: multiple system atrophy


subject: CHEBI:16382

object_name: progressive supranuclear palsy


subject: CHEBI:31617

subject_name: fludeoxyglucose (18F)

object_name: Non-small cell lung cancer stage I


subject: CHEBI:31617

object_name: Non-small cell lung cancer stage II


subject: CHEBI:31617

object_name: Stage I Lung Cancer AJCC v8


subject: CHEBI:31617

object_name: Stage I Lung Cancer AJCC v6


subject: CHEBI:31617

object_name: Stage I Lung Cancer AJCC v7


subject: CHEBI:31617

object_name: Stage II Lung Cancer AJCC v6


subject: CHEBI:31617

object_name: Stage II Lung Cancer AJCC v7


subject: CHEBI:31617

object_name: Stage II Lung Cancer AJCC v8


subject: CHEBI:31617

object_name: Stage IA Lung Non-Small Cell Carcinoma AJCC v7


subject: CHEBI:35523

subject_name: bronchodilator agent

object_name: Adult bronchiectasis


subject: UMLS:C0006280

subject_name: Bronchodilator Agents


subject: PUBCHEM.COMPOUND:3021749


subject: UNII:GR88G0I6UL

subject_name: IPRATROPIUM


subject: PUBCHEM.COMPOUND:657309

subject_name: Ipratropium


subject: CHEBI:149226

subject_name: Fenoterol


subject: CHEBI:31515

subject_name: Domperidone

object_name: Abdominal pain


subject: CHEBI:31515

object_name: Abdominal Pain, CTCAE


subject: CHEBI:94809

subject_name: Itopride


subject: CHEBI:94809


subject: UMLS:C3892043

subject_name: Ibuprofen Injection

object_name: pain agnosia


subject: UMLS:C3892043

object_name: Pain insensitivity


subject: UMLS:C3534681

subject_name: Injection, ibuprofen, 100 mg administered


subject: UMLS:C3534681


subject: UMLS:C0445115

subject_name: Normal saline


subject: UMLS:C0445115


subject: CHEBI:145499

subject_name: Donepezil

object_name: traumatic encephalopathy


subject: CHEBI:145499

object_name: traumatic brain injury


subject: GTOPDB:12652

subject_name: magrolimab

object_name: hematopoietic and lymphoid system neoplasm


subject: UNII:90YIEHRFJ9


subject: UMLS:C3896840


subject: UMLS:C5234034

subject_name: Tepezza

object_name: euthyroid Graves orbitopathy


subject: UMLS:C5234034

object_name: endocrine exophthalmos


subject: CHEBI:70839

subject_name: Dasatinib

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:70839

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: UNII:6QVL057INT

subject_name: Cemiplimab

object_name: clear cell squamous cell skin carcinoma


subject: UNII:6QVL057INT

object_name: sarcomatoid squamous cell skin carcinoma


subject: UNII:6QVL057INT

object_name: acantholytic squamous cell skin carcinoma


subject: UNII:6QVL057INT

object_name: Skin Squamous Cell Carcinoma with Sarcomatoid Differentiation


subject: UNII:6QVL057INT

object_name: Lymphoepithelial tumor of skin


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: CHEBI:63925

subject_name: PhXa 85

object_name: Outcome of Therapy


subject: CHEBI:63925

object_name: Best Overall Response


subject: CHEBI:136044

subject_name: Fimasartan

object_name: Left ventricular hypertrophy


subject: CHEBI:136044

object_name: Left Ventricular Hypertrophy by ECG Finding


subject: UNII:T472P45MG6

subject_name: Dibotermin alfa

object_name: Bone fracture


subject: UNII:T472P45MG6

object_name: Fractured


subject: CHEBI:59213

subject_name: Cefpiramide


subject: CHEBI:59213


subject: CHEBI:195334


subject: CHEBI:195334


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: UNII:D07V79Q44T

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UMLS:C1566164


subject: CHEBI:85990

subject_name: Panobinostat


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: carpal tunnel syndrome 1


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:9667

subject_name: Triamcinolone

object_name: chronic pain (diagnosis)


subject: CHEBI:9667

object_name: Chronic pain


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: coronary artery disorder


subject: CHEBI:89324

object_name: coronary atherosclerosis


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: CHEBI:142708

object_name: diarrhea


subject: CHEBI:142708

object_name: rectal discharge diarrhea (physical finding)


subject: CHEBI:142708

object_name: Diarrhea, CTCAE


subject: PUBCHEM.COMPOUND:54686904

subject_name: tigecycline


subject: PUBCHEM.COMPOUND:54686904


subject: PUBCHEM.COMPOUND:54686904


subject: CHEBI:149836

subject_name: Tigecycline


subject: CHEBI:149836


subject: CHEBI:149836


subject: CHEBI:63631

subject_name: Topiramate

object_name: Uses contraception (finding)


subject: CHEBI:63631

object_name: Menstrual migraine


subject: CHEBI:75998

subject_name: Trametinib

object_name: metastatic malignant neoplasm in the brain


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: Early Stage Breast Carcinoma


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: UNII:3A58010674

subject_name: Pegfilgrastim


subject: UNII:E66Y1F2208


subject: UNII:XX2MN88N5D

subject_name: Efalizumab

object_name: Acne inversa


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: prostate neoplasm


subject: CHEBI:102216

subject_name: Methohexital

object_name: no feeling or sensation of skin


subject: CHEBI:102216

object_name: Sensory Loss


subject: CHEBI:102216

object_name: hypotension


subject: CHEBI:102216

object_name: Hypotension, CTCAE


subject: UMLS:C1879535

subject_name: Acetyl-L-carnitine hydrochloride

object_name: Recurrent Primary Peritoneal Carcinoma


subject: UMLS:C1879535

object_name: Recurrent Fallopian Tube Carcinoma


subject: UMLS:C1879535

object_name: Recurrent ovarian cancer


subject: UMLS:C1879535

object_name: Malignant Ovarian Mixed Epithelial Tumor


subject: UMLS:C1879535

object_name: ovarian seromucinous carcinoma


subject: UMLS:C1879535

object_name: ovarian Brenner tumor


subject: UMLS:C1879535

object_name: ovarian endometrioid adenocarcinoma


subject: UMLS:C1879535

object_name: ovarian clear cell cystadenocarcinoma


subject: UMLS:C1879535

object_name: ovarian serous cystadenocarcinoma


subject: UMLS:C1879535

object_name: ovarian mucinous cystadenocarcinoma


subject: CHEBI:35475

subject_name: non-steroidal anti-inflammatory drug

object_name: arthritis


subject: CHEBI:35475

object_name: Arthritis, CTCAE


subject: CHEBI:35475

object_name: osteoarthritis


subject: UMLS:C0003211

subject_name: Anti-Inflammatory Agents, Non-Steroidal


subject: UMLS:C0003211


subject: UMLS:C0003211


subject: UMLS:C3536840

subject_name: Nonsteroidal Anti-inflammatory Drug [EPC]


subject: UMLS:C3536840


subject: UMLS:C3536840


subject: GTOPDB:8415

subject_name: tanezumab


subject: GTOPDB:8415


subject: UNII:EQL0E9GCX1


subject: UNII:EQL0E9GCX1


subject: UMLS:C2346819


subject: UMLS:C2346819


subject: CHEBI:9356

subject_name: Sultopride

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:9356

object_name: metabolic syndrome X


subject: CHEBI:64045

subject_name: Amisulpride


subject: CHEBI:64045


subject: UNII:RFO6IL3D3M

subject_name: (R)-Naltrexone methylbromide

object_name: Constipation, CTCAE


subject: UNII:RFO6IL3D3M

object_name: opiate dependence


subject: UNII:RFO6IL3D3M

object_name: neoplasm


subject: CHEBI:136007

subject_name: methylnaltrexone


subject: CHEBI:136007


subject: UMLS:C0456388

subject_name: Blood product

object_name: Hemorrhage


subject: MESH:D015054

subject_name: Zymosan

object_name: triple-negative breast carcinoma


subject: MESH:D015054

object_name: Residual Tumor


subject: CHEBI:37671


subject: CHEBI:37671


subject: UMLS:C3833608

subject_name: Glycosade

object_name: hypoglycemia


subject: UMLS:C3833608

object_name: Blood glucose below reference range (finding)


subject: UMLS:C3833608

object_name: Hypoglycemia, CTCAE


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Post-COVID-19 syndrome


subject: CHEBI:73604

object_name: long COVID-19


subject: CHEBI:52717

subject_name: Bortezomib

object_name: lung adenocarcinoma


subject: CHEBI:52717

object_name: minimally invasive lung adenocarcinoma


subject: CHEBI:25523

subject_name: NADP

object_name: Burn injury


subject: CHEBI:18009

subject_name: NADP(+)


subject: CHEBI:3639

subject_name: chlorothalonil


subject: PR:000016053

subject_name: tapasin


subject: CHEBI:17061

subject_name: D-Glutamine


subject: CHEBI:28300

subject_name: glutamine


subject: CHEBI:18050

subject_name: L-Glutamine


subject: UNII:349552KRHK

subject_name: Simendan

object_name: septic shock


subject: UNII:349552KRHK

object_name: cardiomyopathy


subject: CHEBI:193746


subject: CHEBI:193746


subject: CHEBI:50567

subject_name: Levosimendan


subject: CHEBI:50567


subject: CHEBI:50693

subject_name: Milrinone


subject: CHEBI:50693


subject: CHEBI:33569

subject_name: noradrenaline


subject: CHEBI:18357

subject_name: Norepinephrine


subject: CHEBI:31623

subject_name: Fluocinolone acetonide

object_name: glaucoma


subject: CHEBI:31623

object_name: Glaucoma, CTCAE


subject: UMLS:C0034862

subject_name: Vaccines, Recombinant

object_name: Human Immunodeficiency Virus Positive


subject: UMLS:C0034862

object_name: Condyloma anal


subject: UMLS:C0034862

object_name: HIV infection


subject: UMLS:C0034862

object_name: Anal warts


subject: UMLS:C2981812

subject_name: Short Chain Fatty Acid HQK-1004

object_name: lymphoproliferative syndrome


subject: UMLS:C3896818

object_name: head and neck squamous cell carcinoma


subject: UMLS:C3896818

object_name: melanoma


subject: UMLS:C3896818

object_name: squamous cell carcinoma


subject: UMLS:C3896818

object_name: Neck Carcinoma


subject: UMLS:C3896818

object_name: head and neck neoplasm


subject: UMLS:C3896818

object_name: head and neck cancer


subject: UNII:B5TAN0L720

subject_name: Picoplatin

object_name: small cell lung carcinoma


subject: CHEMBL.COMPOUND:CHEMBL3544907

subject_name: PICOPLATIN


subject: CHEBI:30742

subject_name: macrogol

object_name: Fecal Impaction


subject: CHEBI:30742

object_name: Functional constipation


subject: CHEBI:30742

object_name: Chronic idiopathic constipation


subject: PR:000012224

subject_name: glycodelin


subject: PR:000012224


subject: PR:000012224


subject: UMLS:C2348691

subject_name: Fluorine F-18 HX4

object_name: pancreatic neoplasm


subject: UMLS:C2348691

object_name: exocrine pancreatic carcinoma


subject: UMLS:C2348691

object_name: malignant pancreatic neoplasm


subject: UMLS:C3489693

object_name: schizophrenia


subject: CHEBI:75045

subject_name: Dabrafenib


subject: CHEBI:75045

object_name: chordoid glioma


subject: CHEBI:75045

object_name: rosette-forming glioneuronal tumor of fourth ventricule


subject: CHEBI:75045

object_name: extraventricular neurocytoma


subject: CHEBI:75045

object_name: angiocentric glioma


subject: CHEBI:75045

object_name: diffuse astrocytoma


subject: CHEBI:75045

object_name: pleomorphic xanthoastrocytoma


subject: CHEBI:75045

object_name: Childhood Pleomorphic Xanthoastrocytoma


subject: CHEBI:75045

object_name: cerebellar liponeurocytoma


subject: CHEBI:75045

object_name: papillary glioneuronal tumor


subject: CHEBI:75045

object_name: Childhood Anaplastic Oligodendroglioma


subject: CHEBI:75045

object_name: anaplastic oligodendroglioma


subject: CHEBI:75045

object_name: Adult Anaplastic Oligodendroglioma


subject: CHEBI:75045

object_name: childhood oligodendroglioma


subject: CHEBI:75045

object_name: anaplastic ganglioglioma


subject: CHEBI:75045

object_name: neurofibromatosis 1


subject: CHEBI:75045

object_name: neurofibromatosis type 1


subject: CHEBI:75045

object_name: Grade III Childhood Astrocytoma


subject: CHEBI:75045

object_name: Adult Anaplastic Astrocytoma


subject: CHEBI:75045

object_name: anaplastic astrocytoma


subject: CHEBI:75045

object_name: Giant cell astrocytoma


subject: CHEBI:75045

object_name: Neurocytoma


subject: CHEBI:75045

object_name: childhood pilocytic astrocytoma


subject: CHEBI:75045

object_name: Adult Pilocytic Astrocytoma


subject: CHEBI:75045

object_name: Spongioblastoma


subject: CHEBI:75045

object_name: Childhood Diffuse Astrocytoma


subject: CHEBI:75045

object_name: Adult Diffuse Astrocytoma


subject: CHEBI:75045

object_name: ganglioglioma


subject: CHEBI:75045

object_name: ganglioneuroma


subject: CHEBI:75045

object_name: gangliocytoma


subject: CHEBI:75045

object_name: glioblastoma


subject: CHEBI:75045

object_name: Childhood Glioblastoma


subject: CHEBI:75045

object_name: adult glioblastoma


subject: CHEBI:75045

object_name: Childhood Astrocytoma


subject: CHEBI:75045

object_name: glioma susceptibility 1


subject: CHEBI:75045

object_name: astrocytic tumor


subject: CHEBI:75045

object_name: astrocytoma


subject: CHEBI:75998

subject_name: Trametinib


subject: CHEBI:75998

object_name: chordoid glioma


subject: CHEBI:75998

object_name: rosette-forming glioneuronal tumor of fourth ventricule


subject: CHEBI:75998

object_name: extraventricular neurocytoma


subject: CHEBI:75998

object_name: angiocentric glioma


subject: CHEBI:75998

object_name: cerebellar liponeurocytoma


subject: CHEBI:75998

object_name: papillary glioneuronal tumor


subject: CHEBI:75998

object_name: childhood oligodendroglioma


subject: CHEBI:75998

object_name: Giant cell astrocytoma


subject: CHEBI:75998

object_name: Neurocytoma


subject: CHEBI:75998

object_name: childhood pilocytic astrocytoma


subject: CHEBI:75998

object_name: Adult Pilocytic Astrocytoma


subject: CHEBI:75998

object_name: Spongioblastoma


subject: CHEBI:75998

object_name: Childhood Diffuse Astrocytoma


subject: CHEBI:75998

object_name: Adult Diffuse Astrocytoma


subject: CHEBI:75998

object_name: ganglioglioma


subject: CHEBI:75998

object_name: ganglioneuroma


subject: CHEBI:75998

object_name: gangliocytoma


subject: CHEBI:75998

object_name: Childhood Astrocytoma


subject: CHEBI:75998

object_name: astrocytic tumor


subject: CHEBI:75998

object_name: astrocytoma


subject: MESH:C000731016

subject_name: danuglipron

object_name: obesity due to melanocortin 4 receptor deficiency


subject: MESH:C000731016

object_name: obesity


subject: MESH:C000731016

object_name: Obesity, CTCAE


subject: CHEBI:2549

subject_name: Albuterol

object_name: Dyspnea


subject: CHEBI:2549

object_name: Dyspnea, CTCAE


subject: CHEBI:2549

object_name: cardiovascular surgery result: dyspnea


subject: CHEBI:2549

object_name: Moderate chronic obstructive pulmonary disease


subject: CHEBI:31430

subject_name: conivaptan hydrochloride

object_name: kidney disorder


subject: CHEBI:681850

subject_name: Conivaptan


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Metastatic Esophageal Squamous Cell Carcinoma


subject: CHEBI:85994

subject_name: Lenvatinib


subject: UMLS:C4745461

subject_name: ABP 450

object_name: Abnormal morphology of the musculature of the neck


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: Language disorders in children


subject: UMLS:C3154257

subject_name: Gadavist

object_name: metastatic malignant neoplasm in the brain


subject: UMLS:C0388020

subject_name: Gadovist


subject: UMLS:C2713023


subject: HMDB:HMDB0014735

subject_name: Gadoteridol


subject: UMLS:C0245925

subject_name: Prohance


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: Injury of kidney


subject: UMLS:C2608320

subject_name: Aspirin Low Dose

object_name: Adherence To Medication Regime


subject: CHEBI:32139

object_name: Primary malignant neoplasm


subject: CHEBI:32139

object_name: childhood malignant neoplasm


subject: CHEBI:32139

object_name: Malignant obstetric neoplasm


subject: PUBCHEM.COMPOUND:16131310

subject_name: Hepatitis B Vaccines

object_name: viral hepatitis


subject: PUBCHEM.COMPOUND:16131310

object_name: liver disorder


subject: UMLS:C2240392


subject: UMLS:C2240392


subject: UMLS:C0062527

subject_name: Engerix-B


subject: UMLS:C0062527


subject: CHEBI:46245

subject_name: Ubidecarenone

object_name: liver carcinoma


subject: CHEBI:27306

subject_name: vitamin B6


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: thrombocytopenia


subject: GTOPDB:5015

subject_name: leptin

object_name: Weight loss


subject: GTOPDB:5015

object_name: Weight Loss, CTCAE


subject: CHEBI:81571

subject_name: Leptin


subject: CHEBI:81571


subject: UMLS:C3535635

subject_name: leptin human


subject: UMLS:C3535635


subject: CHEBI:124959

subject_name: Tilarginine

object_name: peripheral vascular disease


subject: CHEBI:124959

object_name: peripheral arterial disease


subject: UMLS:C0069477


subject: UMLS:C0069477


subject: CHEBI:114785

subject_name: Erlotinib

object_name: Osteosarcoma recurrent


subject: CHEBI:114785

object_name: Neuroblastoma recurrent


subject: CHEBI:114785

object_name: Recurrent Childhood Ependymoma


subject: CHEBI:114785

object_name: Recurrent Childhood Malignant Germ Cell Tumor


subject: CHEBI:114785

object_name: Recurrent Childhood Medulloblastoma


subject: CHEBI:114785

object_name: Recurrent Childhood Rhabdomyosarcoma


subject: CHEBI:114785

object_name: Recurrent Childhood Soft Tissue Sarcoma


subject: CHEBI:114785

object_name: Recurrent Childhood Cerebral Astrocytoma


subject: CHEBI:114785

object_name: Recurrent Childhood Cerebellar Astrocytoma


subject: CHEBI:114785

object_name: Recurrent Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:15355

subject_name: Acetylcholine

object_name: coronary microvascular disorder


subject: CHEBI:15355

object_name: Inflammation


subject: CHEBI:15355

object_name: myocardial ischemia


subject: CHEBI:15355

object_name: coronary atherosclerosis


subject: CHEBI:15355

object_name: arteriosclerosis disorder


subject: CHEBI:15355

object_name: atherosclerosis


subject: CHEBI:16335

subject_name: Adenosine


subject: CHEBI:16335


subject: CHEBI:16335


subject: CHEBI:16335


subject: CHEBI:25017

subject_name: leucine

object_name: Frail elderly syndrome


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Anterior Cruciate Ligament Injuries


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:8665

subject_name: Pyridostigmine

object_name: Complications of Diabetes Mellitus


subject: DRUGBANK:DB17478

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: DRUGBANK:DB17478

object_name: pancreatic ductal adenocarcinoma


subject: UNII:T21N67B1V3


subject: UNII:T21N67B1V3

object_name: colorectal cancer


subject: UNII:T21N67B1V3

object_name: colorectal carcinoma


subject: UNII:T21N67B1V3


subject: UNII:T21N67B1V3


subject: UMLS:C5236067

subject_name: SHP2 Inhibitor JAB-3312


subject: UMLS:C5236067


subject: UMLS:C5236067


subject: UMLS:C5236067


subject: UMLS:C5236067


subject: UNII:6315412YVF

subject_name: Delafloxacin

object_name: Hepatic impairment


subject: UMLS:C0677666

subject_name: soy protein isolate

object_name: prostate carcinoma


subject: UMLS:C0677666

object_name: prostate cancer


subject: UMLS:C5773196

object_name: pulmonary tuberculosis


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: appendix cancer


subject: UNII:PQX0D8J21J

object_name: small intestine carcinoma


subject: UNII:PQX0D8J21J

object_name: Childhood Small Intestinal Carcinoma


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: DRUGBANK:DB17478


subject: DRUGBANK:DB17478

object_name: appendix carcinoma


subject: DRUGBANK:DB17478


subject: DRUGBANK:DB17478


subject: PUBCHEM.COMPOUND:18772499

subject_name: Inulin

object_name: Dysbiosis


subject: PUBCHEM.COMPOUND:18772499

object_name: Rett syndrome


subject: PUBCHEM.COMPOUND:18772499

object_name: outcomes general quality of life


subject: PUBCHEM.COMPOUND:18772499

object_name: Perceived quality of life


subject: PUBCHEM.COMPOUND:18772499

object_name: Good quality of life


subject: PUBCHEM.COMPOUND:18772499

object_name: epilepsy


subject: UMLS:C2183198

subject_name: diagnostic drugs renal inulin


subject: UMLS:C2183198


subject: UMLS:C2183198


subject: UMLS:C2183198


subject: UMLS:C2183198


subject: UMLS:C2183198


subject: CHEBI:64103

subject_name: sodium butyrate


subject: CHEBI:64103


subject: CHEBI:64103


subject: CHEBI:64103


subject: CHEBI:64103


subject: CHEBI:64103


subject: UMLS:C0142812

subject_name: Sodium Butyrate


subject: UMLS:C0142812


subject: UMLS:C0142812


subject: UMLS:C0142812


subject: UMLS:C0142812


subject: UMLS:C0142812


subject: CHEBI:30772

subject_name: Butyric Acid


subject: CHEBI:30772


subject: CHEBI:30772


subject: CHEBI:30772


subject: CHEBI:30772


subject: CHEBI:30772


subject: CHEBI:36560

subject_name: Zinc oxide


subject: CHEBI:36560


subject: CHEBI:36560


subject: CHEBI:36560


subject: CHEBI:36560


subject: CHEBI:36560


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: membranous glomerulonephritis


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:50438

subject_name: Phenprocoumon

object_name: end stage renal failure


subject: CHEBI:50438

object_name: Chronic uremia


subject: UMLS:C1879913

subject_name: Pyruvate Kinase Inhibitor TLN-232

object_name: melanoma


subject: UMLS:C2752138

subject_name: aloe vera homeopathic preparation

object_name: periodontitis, chronic, adult


subject: UMLS:C2752138

object_name: chronic periodontitis


subject: DRUGBANK:DB13906

subject_name: Aloe vera leaf


subject: DRUGBANK:DB13906


subject: UMLS:C0995182

subject_name: Aloe vera preparation


subject: UMLS:C0995182


subject: CHEBI:62466

subject_name: Prolycopene

object_name: Skin toxicity


subject: CHEBI:62466

object_name: metastatic colorectal cancer


subject: CHEBI:15948

subject_name: Lycopene


subject: CHEBI:15948


subject: PUBCHEM.COMPOUND:21982135

object_name: Inflammation


subject: CHEBI:73038

subject_name: Parecoxib


subject: CHEBI:41423

subject_name: Celecoxib


subject: CHEBI:52717

subject_name: Bortezomib

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: CHEBI:52717

object_name: Diffuse large B-cell lymphoma recurrent


subject: CHEBI:52717

object_name: High Grade B-Cell Lymphoma, Not Otherwise Specified


subject: CHEBI:133021

subject_name: Venetoclax

object_name: Refractory High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements


subject: CHEBI:133021

object_name: Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements


subject: CHEBI:71940

subject_name: Tadalafil

object_name: pancreatic neoplasm


subject: CHEBI:71940

object_name: exocrine pancreatic carcinoma


subject: CHEBI:71940

object_name: malignant pancreatic neoplasm


subject: UMLS:C1251704

subject_name: Lidocaine Patch

object_name: gallbladder disorder


subject: MESH:C113018

subject_name: hypafix


subject: UniProtKB:P0A9E0

subject_name: ARAC_ECOLI Arabinose operon regulatory protein (sprot)

object_name: Adult Lymphoblastic Lymphoma


subject: UniProtKB:P0A9E0

object_name: acute lymphoblastic leukemia


subject: CHEBI:36467

subject_name: Ciguatoxins


subject: CHEBI:36467


subject: CHEBI:204928

subject_name: Cefotaxime


subject: CHEBI:204928


subject: UMLS:C5574748

subject_name: C-Terminal Telopeptide Type 1 Collagen, human


subject: UMLS:C5574748


subject: UMLS:C0010377

subject_name: Crotoxin


subject: UMLS:C0010377


subject: UniProtKB:P41416

subject_name: CXOL_NPVAC Conotoxin-like peptide (sprot)


subject: UniProtKB:P41416


subject: UniProtKB:P47802

subject_name: MTX1_MOUSE Metaxin-1 (sprot)


subject: PR:000010755


subject: CHEBI:9168

subject_name: Sirolimus

object_name: non-small cell lung carcinoma


subject: CHEBI:4055

subject_name: Cytisine

object_name: alcohol abuse


subject: CHEBI:4055

object_name: alcohol dependence


subject: CHEBI:4055

object_name: nicotine dependence


subject: UNII:GN429E725A

subject_name: Nedisertib

object_name: Adult Gliosarcoma


subject: UNII:GN429E725A

object_name: gliosarcoma


subject: UNII:GN429E725A

object_name: Childhood Gliosarcoma


subject: UNII:GN429E725A

object_name: glioblastoma


subject: UNII:GN429E725A

object_name: Childhood Glioblastoma


subject: UNII:GN429E725A

object_name: adult glioblastoma


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: acute kidney failure


subject: CHEBI:73604

object_name: Acute Kidney Injury, CTCAE


subject: CHEBI:73604

object_name: necrotizing soft tissue infection


subject: CHEBI:73604

object_name: peritonitis


subject: CHEBI:180911


subject: CHEBI:45906

subject_name: Suramin


subject: CHEBI:36791

subject_name: Escitalopram

object_name: amyotrophic lateral sclerosis


subject: CHEBI:36791

object_name: multiple sclerosis


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:3723


subject: PUBCHEM.COMPOUND:73505111

subject_name: Ulonivirine

object_name: HIV-1 infection


subject: UNII:4NS011EGKZ

subject_name: ULONIVIRINE


subject: UNII:T42P99266K

subject_name: METHYLENE BLUE

object_name: cytokine release syndrome


subject: UNII:T42P99266K

object_name: Cytokine Release Syndrome, CTCAE


subject: UNII:T42P99266K

object_name: cell-associated neurotoxicity


subject: CHEBI:43830

subject_name: Methylthioninium


subject: CHEBI:43830


subject: CHEBI:43830


subject: CHEBI:114785

subject_name: Erlotinib

object_name: benign neoplasm of pancreas


subject: CHEBI:114785

object_name: Pancreas problem


subject: UMLS:C1688539

object_name: blepharospasm


subject: CHEBI:9241

subject_name: Spironolactone

object_name: Myocardial fibrosis


subject: CHEBI:601027

subject_name: Aliskiren

object_name: Cardiovascular event


subject: CHEBI:2668

subject_name: Amlodipine


subject: CHEBI:5778

subject_name: Hydrochlorothiazide


subject: UMLS:C3864389

subject_name: Congestion Relief

object_name: common cold


subject: PUBCHEM.COMPOUND:24798775

subject_name: Advil Congestion Relief


subject: PUBCHEM.COMPOUND:157010068

subject_name: Calcium citrate

object_name: osteoporosis


subject: PUBCHEM.COMPOUND:157010068

object_name: Encounter due to family history of osteoporosis


subject: PUBCHEM.COMPOUND:157010068

object_name: Osteoporosis, CTCAE 5.0


subject: PUBCHEM.COMPOUND:157010068

object_name: Osteoporosis, CTCAE 3.0


subject: UNII:MLM29U2X85


subject: UNII:MLM29U2X85


subject: UNII:MLM29U2X85


subject: UNII:MLM29U2X85


subject: UMLS:C0719349

subject_name: Citracal


subject: UMLS:C0719349


subject: UMLS:C0719349


subject: UMLS:C0719349


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Disease Progression


subject: UMLS:C0038889

subject_name: Endogenous Surfactants

object_name: Other preterm infants


subject: UMLS:C0038889

object_name: retinopathy of prematurity


subject: UMLS:C0038889

object_name: exudative vitreoretinopathy 1


subject: UMLS:C0038889

object_name: Retinopathy of Prematurity, AE


subject: UMLS:C0038889

object_name: Neonatal disorder


subject: UMLS:C0038889

object_name: fetal growth restriction


subject: UMLS:C0038889

object_name: bronchopulmonary dysplasia


subject: UMLS:C0038889

object_name: Bronchopulmonary Dysplasia, AE


subject: CHEBI:35195

subject_name: surfactant


subject: CHEBI:35195


subject: CHEBI:35195


subject: CHEBI:35195


subject: CHEBI:35195


subject: CHEBI:35195


subject: CHEBI:35195


subject: CHEBI:35195


subject: UMLS:C2825078

subject_name: Surfactant [EPC]


subject: UMLS:C2825078


subject: UMLS:C2825078


subject: UMLS:C2825078


subject: UMLS:C2825078


subject: UMLS:C2825078


subject: UMLS:C2825078


subject: UMLS:C2825078


subject: GTOPDB:12966

subject_name: cadonilimab

object_name: Unresectable Hepatocellular Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4594456

subject_name: CADONILIMAB


subject: UMLS:C4727210

subject_name: Cadonilimab


subject: CHEBI:36791

subject_name: Escitalopram

object_name: schizophreniform disorder


subject: CHEBI:3723

subject_name: Citalopram


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara

object_name: Solid Neoplasm


subject: PUBCHEM.COMPOUND:78357831

subject_name: micafungin

object_name: Candidal meningitis


subject: UMLS:C0879264


subject: UMLS:C5709357

object_name: stroke disorder


subject: UMLS:C5709357

object_name: cerebrovascular disorder


subject: UMLS:C5709357

object_name: Stroke (heart beat)


subject: UMLS:C5709357

object_name: Stroke, CTCAE


subject: DRUGBANK:DB17007

subject_name: Alirinetide


subject: DRUGBANK:DB17007


subject: DRUGBANK:DB17007


subject: DRUGBANK:DB17007


subject: CHEBI:17045

subject_name: Nitrous oxide

object_name: Induced termination of pregnancy in second trimester


subject: CHEBI:42944

subject_name: Galantamine

object_name: cocaine abuse


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Vasovagal syncope


subject: CHEBI:79699

subject_name: Temsirolimus

object_name: thyroid tumor


subject: CHEBI:79699

object_name: thyroid gland carcinoma


subject: CHEBI:79699

object_name: thyroid cancer


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: coronary artery disorder


subject: CHEBI:85078

object_name: carotid artery disorder


subject: GTOPDB:12989

subject_name: toripalimab

object_name: metastatic melanoma


subject: GTOPDB:12989

object_name: Endometrial neoplasm malignant metastatic


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UMLS:C4329337


subject: CHEBI:5441

subject_name: Glyburide

object_name: traumatic encephalopathy


subject: CHEBI:5441

object_name: traumatic brain injury


subject: CHEBI:131361

subject_name: disodium selenite pentahydrate

object_name: Severe Sepsis


subject: UMLS:C0886603

subject_name: Sodium Selenite Pentahydrate


subject: CHEBI:80343

subject_name: Mecasermin

object_name: hereditary endocrine growth disease


subject: GTOPDB:13796

subject_name: serplulimab

object_name: Mismatch Repair Proficient


subject: CHEMBL.COMPOUND:CHEMBL4594550

subject_name: SERPLULIMAB


subject: UMLS:C4745029

subject_name: HLX 10


subject: UMLS:C5206660

subject_name: Anbenitamab

object_name: HER2 positive colorectal cancer


subject: UMLS:C5206660

object_name: HER2 positive biliary tract cancer


subject: UMLS:C4763757

subject_name: Erfonrilimab


subject: UMLS:C4763757


subject: PUBCHEM.COMPOUND:71301229

subject_name: Xelox


subject: PUBCHEM.COMPOUND:71301229


subject: UMLS:C1530450

subject_name: AMG 162

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C5420424

subject_name: Encapsulated Rapamycin

object_name: prostate carcinoma


subject: UMLS:C5420424

object_name: prostate cancer


subject: UMLS:C5854372

subject_name: Anti-DLL3/CD3/CD137 Trispecific Antibody ALPS12

object_name: Small cell lung cancer extensive stage


subject: UNII:O43472U9X8

subject_name: Obinutuzumab


subject: CHEBI:63577

subject_name: Lamivudine

object_name: adult lymphoma


subject: CHEBI:63577

object_name: lymphoma


subject: CHEBI:63577

object_name: pediatric lymphoma


subject: UNII:TC549UFL8P

object_name: postmenopausal osteoporosis


subject: UMLS:C1831848


subject: UMLS:C0728976

subject_name: Control brand of phenylpropanolamine

object_name: atrial fibrillation


subject: UMLS:C0728976

object_name: Atrial Fibrillation by ECG Finding


subject: UMLS:C0728976

object_name: Atrial Fibrillation, CTCAE


subject: UMLS:C0308718

subject_name: CONTROL veterinary product


subject: UMLS:C0308718


subject: UMLS:C0308718


subject: UMLS:C1550141

subject_name: control substance


subject: UMLS:C1550141


subject: UMLS:C1550141


subject: CHEBI:41423

subject_name: Celecoxib

object_name: inflammatory bowel disease


subject: PUBCHEM.COMPOUND:3467

subject_name: gentamicin

object_name: acute intestinal ischemia


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE


subject: CHEBI:6909

subject_name: Metronidazole


subject: UNII:PF8K38CG54

subject_name: Fremanezumab

object_name: Menstrually related migraine


subject: CHEMBL.COMPOUND:CHEMBL2108465

subject_name: GINGER

object_name: Fatty Liver


subject: UNII:C5529G5JPQ

subject_name: ginger extract


subject: UNII:UK4JEM5WVX

object_name: multiple system atrophy


subject: UMLS:C5188472

subject_name: Dantrolene Sodium for Injectable Suspension

object_name: Sunstroke


subject: UMLS:C5188472

object_name: Heat Stroke


subject: CHEBI:4325

subject_name: Dapsone

object_name: pemphigus vulgaris


subject: UMLS:C5828752

object_name: chronic kidney disease


subject: UMLS:C5828752

object_name: Chronic Kidney Disease, CTCAE


subject: UMLS:C5828752

object_name: Diabetes


subject: UMLS:C5828752

object_name: diabetes mellitus


subject: UMLS:C5828752

object_name: Chronic kidney disease, stage 4 (severe)


subject: UMLS:C5828752

object_name: Stage 4 chronic kidney disease


subject: UMLS:C5828752

object_name: Chronic kidney disease, Stage III (moderate)


subject: UMLS:C5828752

object_name: Stage 3 chronic kidney disease


subject: UMLS:C3641686

subject_name: Technetium Tc 99m-3PRGD2

object_name: carcinoma of esophagus


subject: UMLS:C3641686

object_name: esophageal cancer


subject: UMLS:C3641686

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C3641686

object_name: neoplasm of esophagus


subject: CHEBI:145499

subject_name: Donepezil

object_name: Dementia associated with Parkinson's Disease


subject: CHEBI:64312

subject_name: Memantine


subject: CHEBI:64312

object_name: Lewy Bodies


subject: CHEBI:91472

object_name: medulloblastoma


subject: CHEBI:91472

object_name: childhood medulloblastoma


subject: CHEBI:91472

object_name: adult medulloblastoma


subject: CHEBI:7566

subject_name: Nifurtimox


subject: CHEBI:7566


subject: CHEBI:7566


subject: CHEBI:63632

subject_name: Topotecan


subject: CHEBI:63632


subject: CHEBI:63632


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: Chemotherapy-induced change


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: CHEBI:63610

subject_name: Misoprostol

object_name: Abnormal uterine and vaginal bleeding, unspecified


subject: CHEBI:63610

object_name: habitual spontaneous abortion


subject: CHEBI:7936

subject_name: Paroxetine

object_name: BH4-deficient hyperphenylalaninemia A


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Metastatic Kidney Carcinoma


subject: UNII:52CMI0WC3Y

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: UNII:52CMI0WC3Y

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: CHEBI:7496

subject_name: Nelfinavir


subject: CHEBI:7496


subject: CHEBI:7496

object_name: Non-small cell lung cancer recurrent


subject: CHEBI:7496

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:7496


subject: UMLS:C5203518

subject_name: Polidocanol Liquid Injection

object_name: melanoma


subject: UMLS:C5203518

object_name: Cutaneous Melanoma In-Transit Metastasis


subject: CHEBI:46859

subject_name: Polidocanol


subject: CHEBI:46859


subject: CHEBI:87715

subject_name: Prasugrel

object_name: ST Elevation Myocardial Infarction


subject: CHEBI:92223

subject_name: Abexinostat

object_name: follicular lymphoma


subject: CHEBI:27732

subject_name: Caffeine

object_name: Neck pain


subject: CHEBI:27732

object_name: Neck Pain, CTCAE 5.0


subject: CHEBI:27732

object_name: Neck Pain, CTCAE 3.0


subject: CHEBI:27732

object_name: Back Pain, CTCAE 5.0


subject: CHEBI:27732

object_name: Back pain


subject: CHEBI:27732

object_name: Back Pain, CTCAE 3.0


subject: UMLS:C3537192

subject_name: Tumor Necrosis Factor Inhibitors

object_name: ankylosing spondylitis


subject: CHEBI:184662

object_name: hypertriglyceridemia


subject: CHEBI:184662

object_name: Hypertriglyceridemia, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL256907

subject_name: maraviroc


subject: CHEMBL.COMPOUND:CHEMBL256907


subject: CHEBI:63608

subject_name: Maraviroc


subject: CHEBI:63608


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: sickle cell disease


subject: PUBCHEM.COMPOUND:131751553

subject_name: Morellinol

object_name: malaria


subject: CHEBI:176233

subject_name: Tocophersolan


subject: UNII:O03S90U1F2

subject_name: Tocofersolan


subject: UMLS:C0302908

subject_name: Liquid substance

object_name: influenza


subject: CHEBI:3654

subject_name: Chlorthalidone

object_name: Left ventricular hypertrophy


subject: CHEBI:3654

object_name: Left Ventricular Hypertrophy by ECG Finding


subject: CHEBI:31547

subject_name: Eplerenone


subject: CHEBI:31547


subject: UMLS:C0304475

subject_name: Potassium supplement


subject: UMLS:C0304475


subject: CHEBI:29103


subject: CHEBI:29103


subject: CHEBI:26216

subject_name: potassium atom


subject: CHEBI:26216


subject: UMLS:C3714637

subject_name: Potassium Drug Class


subject: UMLS:C3714637


subject: CHEBI:24859

subject_name: iodine atom

object_name: dental caries


subject: CHEBI:17606

subject_name: Iodine


subject: UMLS:C0885449

subject_name: Iodine, Homeopathic preparation


subject: CHEBI:185135

subject_name: Polyvidone


subject: CHEBI:8347

subject_name: Povidone-iodine


subject: UMLS:C3819106

subject_name: Pedia-Lax Probiotic

object_name: Functional constipation


subject: CHEBI:37956

subject_name: histamine antagonist

object_name: breast neoplasm


subject: UMLS:C0740098

subject_name: Antihistamine brand of Diphenhydramine


subject: UMLS:C0019592

subject_name: Histamine H1 Antagonists


subject: UMLS:C3536809

subject_name: Antihistamine [EPC]


subject: CHEBI:31515

subject_name: Domperidone

object_name: chronic kidney disease


subject: CHEBI:231614

subject_name: Nivolumab

object_name: EBV-Related Non-Hodgkin Lymphoma


subject: CHEBI:231614

object_name: Lymphoma, EBV-associated


subject: CHEBI:231614

object_name: EBV-Related Hodgkin Lymphoma


subject: CHEBI:231614

object_name: lymphoproliferative syndrome


subject: CHEBI:231614

object_name: Post transplant Epstein-Barr virus associated lymphoproliferative disorder


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:16335

subject_name: Adenosine

object_name: ischemia


subject: CHEBI:28931


subject: PUBCHEM.COMPOUND:53481006

subject_name: Adenosine 2'-phosphate


subject: CHEBI:456215

subject_name: adenosine 5'-monophosphate(2-)


subject: CHEBI:28971

subject_name: Ampicillin


subject: CHEBI:40050

subject_name: Amprenavir


subject: UMLS:C4084937

subject_name: Antimicrobial Peptide


subject: UMLS:C4285220

subject_name: Absorbable Modified Polymer Hemostatic Powder


subject: CHEBI:27958

subject_name: Cocaine

object_name: Impulsivity


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: premature menopause


subject: CHEBI:89324

object_name: Hot flashes


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: UNII:349552KRHK

subject_name: Simendan

object_name: Heart Decompensation


subject: CHEBI:193746


subject: CHEBI:50567

subject_name: Levosimendan


subject: CHEBI:53766

subject_name: Acenocoumarol

object_name: portal vein thrombosis


subject: CHEBI:53766

object_name: Portal Vein Thrombosis, CTCAE


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: Control of hip fracture risk


subject: UNII:1C6V77QF41

object_name: hip fracture


subject: UNII:1C6V77QF41

object_name: Accidental Falls


subject: UMLS:C2703169

object_name: ovarian cancer


subject: UMLS:C2703169

object_name: ovarian neoplasm


subject: UMLS:C2703169

object_name: ovarian carcinoma


subject: CHEBI:83766

subject_name: Olaparib

object_name: germ cell tumor


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE

object_name: Crohn disease


subject: UNII:K0XHQ9FYT3

subject_name: BK-MDA

object_name: Urinary incontinence


subject: UNII:K0XHQ9FYT3

object_name: Urinary Incontinence, CTCAE 5.0


subject: UNII:K0XHQ9FYT3

object_name: bladder exstrophy


subject: PR:000003710

subject_name: disintegrin and metalloproteinase domain-containing protein 11


subject: PR:000003710


subject: PR:000003710


subject: PR:000001994

subject_name: C-C motif chemokine 22


subject: PR:000001994


subject: PR:000001994


subject: UMLS:C2986857

subject_name: Y-shape Branched Pegylated Filgrastim

object_name: Childhood Breast Carcinoma


subject: UMLS:C2986857

object_name: breast carcinoma


subject: UMLS:C2986857

object_name: breast cancer


subject: UMLS:C2986857

object_name: non-small cell lung carcinoma


subject: UMLS:C4319834

subject_name: B-cell lymphoma 2 inhibitor

object_name: T-lymphoblastic lymphoma


subject: UMLS:C4319834

object_name: Refractory Lymphoma


subject: UMLS:C4319834

object_name: Refractory Leukemia


subject: UMLS:C4319834

object_name: Recurrent disease


subject: UNII:R8DG7T2D3A

subject_name: FERUMOXYTOL

object_name: Pregnant


subject: UNII:R8DG7T2D3A

object_name: preeclampsia


subject: UNII:R8DG7T2D3A

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UNII:R8DG7T2D3A

object_name: obesity


subject: UNII:R8DG7T2D3A

object_name: Obesity, CTCAE


subject: UNII:CLH5FT6412

subject_name: Ferumoxytol


subject: UNII:CLH5FT6412


subject: UNII:CLH5FT6412


subject: UNII:CLH5FT6412


subject: UNII:CLH5FT6412


subject: CHEBI:46726

subject_name: magnetite


subject: CHEBI:46726


subject: CHEBI:46726


subject: CHEBI:46726


subject: CHEBI:46726


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]

object_name: Symptomatic irreversible pulpitis


subject: UNII:Q830PW7520

subject_name: CODEINE


subject: PUBCHEM.COMPOUND:2828


subject: CHEBI:57871


subject: CHEBI:16714

subject_name: Codeine


subject: CHEBI:27732

subject_name: Caffeine


subject: CHEBI:5613

subject_name: Haloperidol

object_name: psychiatric emergencies


subject: CHEBI:5613

object_name: Aggressive behavior


subject: CHEBI:5613

object_name: Aggression


subject: CHEBI:8461

subject_name: Promethazine

object_name: Agitation, CTCAE 3.0


subject: CHEBI:8461

object_name: Agitation, CTCAE 5.0


subject: CHEBI:8461


subject: CHEBI:8461


subject: CHEBI:8461


subject: UMLS:C5442122

subject_name: VITAMIN B

object_name: beriberi


subject: UMLS:C5442122

object_name: Thiamine deficiency


subject: UMLS:C5442122

object_name: Decreased circulating vitamin B1 concentration


subject: UMLS:C5442122

object_name: Sepsis


subject: UMLS:C5442122

object_name: Sepsis, CTCAE


subject: UMLS:C1704763

subject_name: B Vitamin Family


subject: UMLS:C1704763


subject: UMLS:C1704763


subject: UMLS:C1704763


subject: UMLS:C1704763


subject: CHEBI:75769

subject_name: B vitamin


subject: CHEBI:75769


subject: CHEBI:75769


subject: CHEBI:75769


subject: CHEBI:75769


subject: CHEMBL.COMPOUND:CHEMBL2108015

subject_name: VITAMIN B COMPLEX


subject: CHEMBL.COMPOUND:CHEMBL2108015


subject: CHEMBL.COMPOUND:CHEMBL2108015


subject: CHEMBL.COMPOUND:CHEMBL2108015


subject: CHEMBL.COMPOUND:CHEMBL2108015


subject: UMLS:C2703133

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UMLS:C2703133

object_name: juvenile myelomonocytic leukemia


subject: UMLS:C2703133

object_name: chronic myelomonocytic leukemia


subject: UMLS:C2703133

object_name: acute myeloid leukemia


subject: UMLS:C2703133

object_name: Myelodysplasia


subject: CHEBI:231350

subject_name: Pacritinib


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: IgA vasculitis


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: UMLS:C1704263

subject_name: green tea extract

object_name: EXCESS LMW-DNA


subject: UMLS:C1704263

object_name: Autoimmune reaction


subject: DRUGBANK:DB14307

subject_name: Green tea leaf


subject: DRUGBANK:DB14307


subject: PUBCHEM.COMPOUND:3035406

subject_name: Caspofungin

object_name: chronic obstructive pulmonary disease


subject: CHEBI:107736

subject_name: Metoclopramide

object_name: Postoperative ileus


subject: UMLS:C1699394

subject_name: Hylenex

object_name: multifocal motor neuropathy


subject: CHEBI:8060

subject_name: Phenelzine

object_name: hormone-resistant prostate carcinoma


subject: CHEBI:8060

object_name: Adenocarcinoma of the prostate metastatic


subject: MESH:C578457

object_name: glaucoma


subject: MESH:C578457

object_name: Glaucoma, CTCAE


subject: MESH:C578457

object_name: ocular hypertension


subject: MESH:C578457

object_name: Ocular hypertension


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: osteoporosis


subject: CHEBI:46195

object_name: Encounter due to family history of osteoporosis


subject: CHEBI:46195

object_name: Osteoporosis, CTCAE 5.0


subject: CHEBI:46195

object_name: Osteoporosis, CTCAE 3.0


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: CHEBI:38562

subject_name: Fluvastatin


subject: CHEBI:38562


subject: CHEBI:38562


subject: CHEBI:38562


subject: UMLS:C5203351

subject_name: Furosemide Liquid Injection

object_name: Transitory tachypnea of newborn


subject: UMLS:C4048177

subject_name: furosemide injection


subject: UMLS:C0009906

subject_name: Combined Oral Contraceptives

object_name: migraine


subject: UMLS:C0009906

object_name: migraine with or without aura, susceptibility to, 1


subject: CHEBI:50249

subject_name: anticoagulant

object_name: Anticoagulant-induced bleeding


subject: UMLS:C0003280

subject_name: Anticoagulants


subject: UMLS:C3536711

subject_name: Anti-coagulant [EPC]

object_name: Intracranial hemorrhage


subject: UMLS:C3536711


subject: PUBCHEM.COMPOUND:3844471

subject_name: Irofulven

object_name: leukemia


subject: PUBCHEM.COMPOUND:3844471

object_name: childhood leukemia


subject: PUBCHEM.COMPOUND:3844471

object_name: Myelodysplasia


subject: CHEBI:94805

subject_name: Ataluren

object_name: inborn disorder of amino acid metabolism


subject: UMLS:C5444737

subject_name: Flaxseed antigen

object_name: Androgen excess


subject: DRUGBANK:DB10708

subject_name: Flax seed


subject: CHEBI:71957

object_name: endometrial cancer


subject: CHEBI:71957

object_name: uterine corpus cancer


subject: CHEBI:71957

object_name: endometrial carcinoma


subject: CHEBI:71957

object_name: endometrium neoplasm


subject: UNII:60ES45KTMK

subject_name: Pilaralisib


subject: UNII:60ES45KTMK


subject: UNII:60ES45KTMK


subject: UNII:60ES45KTMK


subject: UMLS:C3657458


subject: UMLS:C3657458


subject: UMLS:C3657458


subject: UMLS:C3657458


subject: CHEMBL.COMPOUND:CHEMBL4297877

subject_name: BALSTILIMAB

object_name: Stage IV Colorectal Cancer AJCC v8


subject: CHEMBL.COMPOUND:CHEMBL4297877

object_name: Stage III Colorectal Cancer AJCC v8


subject: CHEMBL.COMPOUND:CHEMBL4297877

object_name: Metastatic Colorectal Adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297877

object_name: Advanced Colorectal Adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297877

object_name: Stage IV Rectal Cancer AJCC v8


subject: CHEMBL.COMPOUND:CHEMBL4297877

object_name: Stage III Rectal Cancer AJCC v8


subject: CHEMBL.COMPOUND:CHEMBL4297877

object_name: Metastatic rectal adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297877

object_name: Advanced Rectal Adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297877

object_name: Adenocarcinoma of colon metastatic


subject: CHEMBL.COMPOUND:CHEMBL4297877

object_name: Advanced Colon Adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297877

object_name: Stage III Colon Cancer AJCC v8


subject: CHEMBL.COMPOUND:CHEMBL4297877

object_name: Stage IV Colon Cancer AJCC v8


subject: UMLS:C4526708


subject: UMLS:C4526708


subject: UMLS:C4526708


subject: UMLS:C4526708


subject: UMLS:C4526708


subject: UMLS:C4526708


subject: UMLS:C4526708


subject: UMLS:C4526708


subject: UMLS:C4526708


subject: UMLS:C4526708


subject: UMLS:C4526708


subject: UMLS:C4526708


subject: CHEMBL.COMPOUND:CHEMBL4650435

subject_name: BOTENSILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4650435


subject: CHEMBL.COMPOUND:CHEMBL4650435


subject: CHEMBL.COMPOUND:CHEMBL4650435


subject: CHEMBL.COMPOUND:CHEMBL4650435


subject: CHEMBL.COMPOUND:CHEMBL4650435


subject: CHEMBL.COMPOUND:CHEMBL4650435


subject: CHEMBL.COMPOUND:CHEMBL4650435


subject: CHEMBL.COMPOUND:CHEMBL4650435


subject: CHEMBL.COMPOUND:CHEMBL4650435


subject: CHEMBL.COMPOUND:CHEMBL4650435


subject: CHEMBL.COMPOUND:CHEMBL4650435


subject: UMLS:C4764272

subject_name: Botensilimab


subject: UMLS:C4764272


subject: UMLS:C4764272


subject: UMLS:C4764272


subject: UMLS:C4764272


subject: UMLS:C4764272


subject: UMLS:C4764272


subject: UMLS:C4764272


subject: UMLS:C4764272


subject: UMLS:C4764272


subject: UMLS:C4764272


subject: UMLS:C4764272


subject: CHEBI:68646

subject_name: REGORAFENIB


subject: CHEBI:68646


subject: CHEBI:68647

subject_name: Regorafenib


subject: CHEBI:68647


subject: CHEBI:74947

subject_name: Thalidomide

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: CHEBI:74947

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: DRUGBANK:DB15844

subject_name: CVnCoV

object_name: Immunization reaction


subject: DRUGBANK:DB15844

object_name: Complication of transplanted liver


subject: DRUGBANK:DB15844

object_name: Complication of transplanted lung


subject: DRUGBANK:DB15844

object_name: Vaccine adverse reaction


subject: DRUGBANK:DB15844

object_name: Vaccine response impaired


subject: MESH:C000722934

subject_name: CVnCoV COVID-19 vaccine


subject: MESH:C000722934


subject: MESH:C000722934


subject: MESH:C000722934


subject: MESH:C000722934


subject: UMLS:C5889747

subject_name: COVID-19 mRNA Vaccine [EPC]


subject: UMLS:C5889747


subject: UMLS:C5889747


subject: UMLS:C5889747


subject: UMLS:C5889747


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: UNII:DPT0O3T46P

object_name: Treatment related acute myeloid leukaemia


subject: UNII:DPT0O3T46P

object_name: Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: Infant Nutrition Disorders


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: MESH:D006495

subject_name: Heparin, Low-Molecular-Weight

object_name: Severe Fever with Thrombocytopenia Syndrome


subject: UMLS:C3536766

subject_name: Low Molecular Weight Heparin [EPC]


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: UNII:I031V2H011

subject_name: Tocilizumab


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous


subject: UMLS:C2930445

subject_name: silexan

object_name: post-traumatic stress disorder


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: malignant glioma


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Ewing sarcoma of bone


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: UNII:T5IRO3534A

object_name: Ewing sarcoma


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: PUBCHEM.COMPOUND:3717450


subject: CHEBI:28445

subject_name: vincristine


subject: UMLS:C5669917

subject_name: Zirconium Zr 89-DFO-YS5

object_name: prostate carcinoma


subject: UMLS:C5669917

object_name: prostate cancer


subject: UMLS:C5669917

object_name: Metastatic castration-resistant prostate cancer


subject: UMLS:C2958914

subject_name: INJECTION, INCOBOTULINUMTOXIN A, 1 UNIT

object_name: borderline personality disorder


subject: CHEBI:63607

subject_name: Linezolid

object_name: thrombocytopenia


subject: CHEBI:16347

subject_name: Levocarnitine

object_name: myocardial infarction


subject: CHEBI:16347

object_name: Myocardial Infarction, CTCAE


subject: CHEBI:16347

object_name: Myocardial Infarction by ECG Finding


subject: CHEBI:16347

object_name: Myocardial Reperfusion Injury


subject: CHEBI:5790

subject_name: Hydromorphone

object_name: migraine


subject: CHEBI:5790

object_name: migraine with or without aura, susceptibility to, 1


subject: CHEBI:8435

subject_name: Prochlorperazine


subject: CHEBI:8435


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: Cough


subject: UMLS:C0013227

object_name: Cough, CTCAE


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: CHEBI:145994

subject_name: Remdesivir

object_name: severe acute respiratory syndrome


subject: CHEBI:145994

object_name: Coronavinae infectious disease


subject: CHEBI:47898

subject_name: Epirubicin

object_name: hormone receptor-positive breast cancer


subject: CHEBI:144094

subject_name: bicalutamide

object_name: Adenocarcinoma of the prostate stage IV


subject: CHEBI:144094

object_name: PSA Level Greater than Two


subject: CHEBI:5523

subject_name: Goserelin


subject: CHEBI:5523


subject: UMLS:C0149473

subject_name: Zoladex


subject: UMLS:C0149473


subject: CHEBI:6427

subject_name: Leuprolide


subject: CHEBI:6427


subject: CHEBI:4953

subject_name: Exemestane

object_name: Atypical hyperplasia


subject: CHEBI:4953

object_name: Endometrial Intraepithelial Neoplasia


subject: CHEBI:4953

object_name: FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma


subject: CHEBI:4953

object_name: FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma


subject: DRUGBANK:DB14101

subject_name: Soy isoflavones

object_name: tongue cancer


subject: DRUGBANK:DB14101

object_name: tongue carcinoma


subject: DRUGBANK:DB14101

object_name: Stage II Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: DRUGBANK:DB14101

object_name: Laryngeal squamous cell carcinoma recurrent


subject: DRUGBANK:DB14101

object_name: Stage I Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: DRUGBANK:DB14101

object_name: Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: DRUGBANK:DB14101

object_name: Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7


subject: DRUGBANK:DB14101

object_name: Oropharyngeal squamous cell carcinoma stage II


subject: DRUGBANK:DB14101

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: DRUGBANK:DB14101

object_name: Hypopharyngeal squamous cell carcinoma stage II


subject: DRUGBANK:DB14101

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: DRUGBANK:DB14101

object_name: Oropharyngeal squamous cell carcinoma stage I


subject: DRUGBANK:DB14101

object_name: Oropharyngeal squamous cell carcinoma stage III


subject: DRUGBANK:DB14101

object_name: Hypopharyngeal squamous cell carcinoma stage I


subject: DRUGBANK:DB14101

object_name: Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: DRUGBANK:DB14101

object_name: Stage II Laryngeal Verrucous Carcinoma AJCC v6 and v7


subject: DRUGBANK:DB14101

object_name: Hypopharyngeal squamous cell carcinoma stage III


subject: DRUGBANK:DB14101

object_name: Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: DRUGBANK:DB14101

object_name: Laryngeal verrucous carcinoma recurrent


subject: DRUGBANK:DB14101

object_name: Stage II Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: DRUGBANK:DB14101

object_name: Verrucous carcinoma of the oral cavity stage II


subject: DRUGBANK:DB14101

object_name: Stage I Laryngeal Verrucous Carcinoma AJCC v6 and v7


subject: DRUGBANK:DB14101

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: DRUGBANK:DB14101

object_name: Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7


subject: DRUGBANK:DB14101

object_name: Stage I Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: DRUGBANK:DB14101

object_name: Verrucous carcinoma of the oral cavity recurrent


subject: DRUGBANK:DB14101

object_name: Stage III Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: DRUGBANK:DB14101

object_name: Stage IVA Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: DRUGBANK:DB14101

object_name: Stage IVA Laryngeal Verrucous Carcinoma AJCC v7


subject: DRUGBANK:DB14101

object_name: Verrucous carcinoma of the oral cavity stage I


subject: DRUGBANK:DB14101

object_name: Verrucous carcinoma of the oral cavity stage III


subject: DRUGBANK:DB14101

object_name: Stage IVA Oral Cavity Verrucous Carcinoma


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: coronary microvascular disorder


subject: PUBCHEM.COMPOUND:3062

subject_name: Cogoxin

object_name: pancreatic neoplasm


subject: PUBCHEM.COMPOUND:3062

object_name: exocrine pancreatic carcinoma


subject: PUBCHEM.COMPOUND:3062

object_name: malignant pancreatic neoplasm


subject: PUBCHEM.COMPOUND:3062

object_name: pancreatic adenocarcinoma


subject: CHEBI:145795


subject: CHEBI:145795


subject: CHEBI:145795


subject: CHEBI:145795


subject: CHEBI:4551

subject_name: Digoxin


subject: CHEBI:4551


subject: CHEBI:4551


subject: CHEBI:4551


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Metastatic Soft Tissue Sarcoma


subject: CHEBI:4026

object_name: Advanced Soft Tissue Sarcoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:16240

subject_name: Hioxyl

object_name: periapical periodontitis


subject: CHEBI:16240

object_name: Root canal infection


subject: CHEBI:24757

subject_name: Hypochlorite


subject: CHEBI:24757


subject: UNII:BU8V88OWIQ

subject_name: Sodium hydrogen sulfate


subject: UNII:BU8V88OWIQ


subject: PUBCHEM.COMPOUND:162462688

subject_name: Sodium;sulfate


subject: PUBCHEM.COMPOUND:162462688


subject: CHEBI:32149

subject_name: Sodium sulfate


subject: CHEBI:32149


subject: UNII:2US4FK1EPV

subject_name: Cimlanod

object_name: kidney failure


subject: UNII:2US4FK1EPV

object_name: Renal Failure, CTCAE


subject: UNII:2US4FK1EPV

object_name: heart failure


subject: UNII:2US4FK1EPV

object_name: congestive heart failure


subject: UMLS:C5139950


subject: UMLS:C5139950


subject: UMLS:C5139950


subject: UMLS:C5139950


subject: UMLS:C4271578

subject_name: sofosbuvir / velpatasvir

object_name: hepatitis C


subject: UMLS:C4271578

object_name: lung transplant infection


subject: CHEBI:75551


subject: CHEBI:75551


subject: CHEBI:9241

subject_name: Spironolactone

object_name: Fatty Liver


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: Nephrotic syndrome in children


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:7009

subject_name: Moxonidine

object_name: Obesity-Associated Insulin Resistance


subject: PUBCHEM.COMPOUND:16131310

subject_name: Hepatitis B Vaccines

object_name: Adverse reaction to hepatitis B vaccine


subject: DRUGBANK:DB11627

subject_name: Hepatitis B Vaccine (Recombinant)


subject: UMLS:C2240392


subject: UMLS:C0062527

subject_name: Engerix-B


subject: CHEBI:172922

subject_name: ethylzingerone


subject: UNII:ML6O5CFJ3J


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: systolic heart failure


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: Myalgia


subject: UMLS:C3536908

subject_name: Omega-3 Fatty Acid [EPC]


subject: UMLS:C3536908

object_name: Body Composition


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: Infection of heart transplant


subject: PUBCHEM.COMPOUND:70789204

object_name: Heart transplant failure and rejection


subject: UMLS:C5544131


subject: UNII:KG6VO684Z6

subject_name: Polatuzumab vedotin

object_name: Diffuse large B-cell lymphoma recurrent


subject: UNII:KG6VO684Z6

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: UMLS:C3641728


subject: UMLS:C3641728


subject: UMLS:C2346816

object_name: Solid Neoplasm


subject: UNII:AF75XOF6W3

subject_name: Relatlimab

object_name: basal cell carcinoma


subject: UNII:AF75XOF6W3

object_name: skin basal cell carcinoma


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: CHEBI:167574

subject_name: Semaglutide

object_name: cardiomyopathy


subject: CHEBI:167574

object_name: Heart failure with normal ejection fraction


subject: UMLS:C5575040

object_name: non-small cell lung carcinoma


subject: UNII:FF33NL9U5G

object_name: type 2 diabetes mellitus


subject: UMLS:C4310563


subject: UMLS:C3897088

subject_name: Oral Azacitidine

object_name: Angioimmunoblastic T-cell lymphoma refractory


subject: UMLS:C3897088

object_name: Angioimmunoblastic T-cell lymphoma recurrent


subject: UMLS:C5782830

subject_name: ROPivacaine 0.5% injectable solution

object_name: respiratory paralysis


subject: UMLS:C5782830

object_name: Diaphragmatic paralysis


subject: PUBCHEM.COMPOUND:147817927

subject_name: EDECESERTIB

object_name: cutaneous lupus erythematosus


subject: DRUGBANK:DB18917

subject_name: Edecesertib


subject: UNII:9G6U5L461Q

subject_name: Icotinib

object_name: lung cancer


subject: UNII:9G6U5L461Q

object_name: lung neoplasm


subject: UNII:9G6U5L461Q

object_name: lung carcinoma


subject: UMLS:C3153749

subject_name: AMMONIA N-13 37.5 mCi in 1 mL INTRAVENOUS INJECTION

object_name: coronary artery disorder


subject: UMLS:C3153749

object_name: coronary atherosclerosis


subject: UMLS:C3153749

object_name: heart disorder


subject: UMLS:C3153749

object_name: myocardial ischemia


subject: UMLS:C3153749

object_name: peripheral vascular disease


subject: UMLS:C3153749

object_name: aneurysm


subject: UMLS:C3153749

object_name: cardiovascular disorder


subject: UMLS:C3153749

object_name: arteriosclerosis disorder


subject: GTOPDB:4942

subject_name: GM-CSF

object_name: cutaneous leishmaniasis


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: PR:000005931


subject: UMLS:C0376563

subject_name: Recombinant Granulocyte-Macrophage Colony-Stimulating Factors


subject: UMLS:C5239502

subject_name: Salovum

object_name: Head Injury


subject: CHEBI:94534

subject_name: olanzapine

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:94534

object_name: metabolic syndrome X


subject: CHEBI:94534

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:94534

object_name: obesity


subject: CHEBI:94534

object_name: Obesity, CTCAE


subject: UMLS:C1527137

subject_name: Recombinant melatonin


subject: UMLS:C1527137


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:16796


subject: MESH:C000621615

object_name: Acute migraine


subject: UMLS:C2983753

object_name: prostate carcinoma


subject: UMLS:C2983753

object_name: prostate cancer


subject: CHEBI:230682

subject_name: Indoximod

object_name: metastatic prostate carcinoma


subject: UMLS:C4045546


subject: CHEBI:71023

subject_name: Alcaftadine

object_name: Rhinoconjunctivitis


subject: UMLS:C5854409

subject_name: Ruxoprubart

object_name: IgA Nephropathy


subject: UMLS:C2346560

object_name: Metastatic Renal Cell Carcinoma


subject: UMLS:C2346560

object_name: Metastatic Renal Cell Cancer


subject: UMLS:C2346560

object_name: metastatic melanoma


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: Ulcerative colitis in remission


subject: CHEBI:187893

subject_name: Baclofen

object_name: Low back pain


subject: CHEBI:6797

subject_name: Metaxalone


subject: CHEBI:63629

subject_name: Tizanidine


subject: UMLS:C2607623

object_name: post operative nausea and vomiting


subject: UNII:P1T1143877

object_name: heart failure


subject: UNII:P1T1143877

object_name: Heart Failure, CTCAE


subject: DRUGBANK:DB15195

subject_name: Mibenratide


subject: DRUGBANK:DB15195


subject: UMLS:C4309073


subject: UMLS:C4309073


subject: CHEBI:3638

subject_name: Chloroquine

object_name: Malaria, antepartum


subject: CHEBI:18248

subject_name: Iron


subject: CHEBI:29034

subject_name: Ferric cation


subject: UMLS:C1166521

subject_name: Ferrum metallicum, Homeopathic preparation


subject: UMLS:C3714701

subject_name: Iron Drug Class


subject: CHEBI:27470

subject_name: Folic acid


subject: DRUGBANK:DB17475

subject_name: Incomplete Freund's adjuvant

object_name: malaria


subject: DRUGBANK:DB17475


subject: CHEBI:25255

subject_name: methyl methanesulfonate


subject: CHEBI:25255


subject: CHEBI:74820

subject_name: Ser-Pro


subject: CHEBI:80308

subject_name: substance P


subject: PR:000016275

subject_name: trefoil factor 2


subject: UniProtKB:Q03404

subject_name: TFF2_MOUSE Trefoil factor 2 (sprot)


subject: CHEBI:134703

subject_name: Fluciclovine (18F)

object_name: Advanced prostate cancer


subject: CHEBI:134703


subject: CHEBI:134703

object_name: Metastatic Prostate Neuroendocrine Carcinoma


subject: GTOPDB:12966

subject_name: cadonilimab

object_name: carcinoma of esophagus


subject: CHEMBL.COMPOUND:CHEMBL4594456

subject_name: CADONILIMAB


subject: UMLS:C4727210

subject_name: Cadonilimab


subject: UMLS:C0937629

subject_name: Gymnema sylvestre preparation

object_name: abdominal obesity-metabolic syndrome


subject: UMLS:C0937629

object_name: metabolic syndrome X


subject: CHEBI:94807

subject_name: Nitazoxanide

object_name: rheumatoid arthritis


subject: UMLS:C2698683

subject_name: PADRE-CMV Fusion Peptide Vaccine

object_name: Non-Cancer Diagnosis


subject: CHEMBL.COMPOUND:CHEMBL2103793

subject_name: AGATOLIMOD SODIUM


subject: UNII:I4Z5C8FM6H


subject: DRUGBANK:DB15018

subject_name: Agatolimod


subject: UMLS:C2699920

subject_name: Tetanus-CMV Fusion Peptide Vaccine


subject: PUBCHEM.COMPOUND:91820602

subject_name: Hyaluronidase

object_name: endometrial carcinoma


subject: PUBCHEM.COMPOUND:91820602

object_name: endometrial serous adenocarcinoma


subject: PUBCHEM.COMPOUND:91820602

object_name: carcinosarcoma of the corpus uteri


subject: PUBCHEM.COMPOUND:91820602

object_name: endometrial endometrioid adenocarcinoma


subject: PUBCHEM.COMPOUND:91820602

object_name: endometrium adenocarcinoma


subject: PUBCHEM.COMPOUND:91820602

object_name: endometrial clear cell adenocarcinoma


subject: PUBCHEM.COMPOUND:91820602

object_name: endometrial undifferentiated carcinoma


subject: PUBCHEM.COMPOUND:91820602

object_name: undifferentiated carcinoma of the corpus uteri


subject: PUBCHEM.COMPOUND:91820602

object_name: Endometrial Dedifferentiated Carcinoma


subject: PUBCHEM.COMPOUND:91820602

object_name: endometrial mixed adenocarcinoma


subject: UMLS:C5389886

subject_name: hyaluronidase-zzxf


subject: UMLS:C5389886


subject: UMLS:C5389886


subject: UMLS:C5389886


subject: UMLS:C5389886


subject: UMLS:C5389886


subject: UMLS:C5389886


subject: UMLS:C5389886


subject: UMLS:C5389886


subject: UMLS:C5389886


subject: UNII:K16AIQ8CTM

subject_name: Pertuzumab


subject: UNII:K16AIQ8CTM


subject: UNII:K16AIQ8CTM


subject: UNII:K16AIQ8CTM


subject: UNII:K16AIQ8CTM


subject: UNII:K16AIQ8CTM


subject: UNII:K16AIQ8CTM


subject: UNII:K16AIQ8CTM


subject: UNII:K16AIQ8CTM


subject: CHEBI:231601

subject_name: trastuzumab


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C1699394

subject_name: Hylenex


subject: UMLS:C1699394


subject: UMLS:C1699394


subject: UMLS:C1699394


subject: UMLS:C1699394


subject: UMLS:C1699394


subject: UMLS:C1699394


subject: UMLS:C1699394


subject: UMLS:C1699394


subject: UMLS:C1699394


subject: UMLS:C0751598

subject_name: Alferon

object_name: precancerous condition


subject: UMLS:C0751598

object_name: unspecified adult solid tumor, protocol specific


subject: UMLS:C0751598

object_name: myeloproliferative neoplasm


subject: UMLS:C0751598

object_name: Myelodysplasia


subject: UMLS:C1328728


subject: UMLS:C1328728


subject: UMLS:C1328728


subject: UMLS:C1328728

object_name: leukemia


subject: UMLS:C1328728

object_name: childhood leukemia


subject: CHEBI:2453

subject_name: Acyclovir

object_name: Drug use for unapproved schedule


subject: UMLS:C2984024

subject_name: Ferric Carboxymaltose Solution

object_name: infertility


subject: UMLS:C5203385

subject_name: Ferric Carboxymaltose Liquid Injection


subject: UNII:6897GXD6OE


subject: CHEBI:94463

object_name: Liver Fibrosis


subject: CHEBI:63580

subject_name: Ribavirin


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: prostate carcinoma


subject: CHEBI:38290

object_name: prostate cancer


subject: CHEBI:38290

object_name: castration-resistant prostate carcinoma


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: CHEBI:22652


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C4086546

subject_name: Liposomal Bupivacaine

object_name: peripheral vascular disease


subject: UMLS:C4086546

object_name: systemic sclerosis


subject: UMLS:C4086546

object_name: diffuse scleroderma


subject: UMLS:C4086546

object_name: Raynaud disease


subject: UMLS:C4086546

object_name: scleroderma, familial progressive


subject: UMLS:C4086546

object_name: CREST syndrome


subject: CHEBI:15367

subject_name: Tretinoin

object_name: Advanced Melanoma


subject: CHEBI:15367

object_name: Metastatic Cutaneous Melanoma


subject: CHEBI:15367

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: CHEBI:15367

object_name: metastatic melanoma


subject: CHEBI:15367

object_name: Stage III Cutaneous Melanoma AJCC v6


subject: UMLS:C4725934

subject_name: Encochleated Amphotericin B

object_name: Cryptococcal infections


subject: CHEBI:91450

subject_name: Sapanisertib

object_name: ovarian neoplasm


subject: CHEBI:91450

object_name: ovarian carcinosarcoma


subject: CHEBI:91450

object_name: fallopian tube carcinoma


subject: CHEBI:91450

object_name: fallopian tube cancer


subject: CHEBI:91450

object_name: primary peritoneal carcinoma


subject: CHEBI:91450

object_name: papillary serous cystadenocarcinoma


subject: CHEBI:91450

object_name: peritoneal carcinoma


subject: CHEBI:91450

object_name: primary peritoneal serous adenocarcinoma


subject: CHEBI:91450

object_name: peritoneal serous adenocarcinoma


subject: CHEBI:91450

object_name: fallopian tube neoplasm


subject: CHEBI:91450

object_name: ovarian clear cell adenocarcinoma


subject: CHEBI:91450

object_name: ovarian serous adenocarcinoma


subject: UNII:1B8447E7YI

subject_name: CLOMIPHENE CITRATE

object_name: Ovulation disorder


subject: CHEBI:3752

subject_name: Clomifene


subject: CHEBI:9932

subject_name: Vancomycin hydrochloride

object_name: Surgical Wound Infection


subject: UMLS:C0205992

subject_name: vancomycin hydrochloride


subject: CHEBI:7773

subject_name: Ondansetron

object_name: Nausea and vomiting caused by drug


subject: PUBCHEM.COMPOUND:3080587

subject_name: Megestrol

object_name: Chemotherapy-induced nausea and vomiting


subject: PUBCHEM.COMPOUND:3080587

object_name: Tumor Mass


subject: CHEBI:32188

subject_name: Tegafur

object_name: Metastatic malignant neoplasm to liver


subject: CHEBI:230352

subject_name: Desidustat


subject: UMLS:C5198569

subject_name: desidustat


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE

object_name: acute myocardial infarction


subject: PUBCHEM.COMPOUND:155543961

object_name: Acute Myocardial Infarction by ECG Finding


subject: UMLS:C1099192


subject: UMLS:C1099192


subject: CHEBI:144094

subject_name: bicalutamide

object_name: osteoporosis


subject: CHEBI:144094

object_name: Encounter due to family history of osteoporosis


subject: CHEBI:144094

object_name: Osteoporosis, CTCAE 5.0


subject: CHEBI:144094

object_name: Osteoporosis, CTCAE 3.0


subject: CHEBI:5523

subject_name: Goserelin


subject: CHEBI:5523


subject: CHEBI:5523


subject: CHEBI:5523


subject: UMLS:C0149473

subject_name: Zoladex


subject: UMLS:C0149473


subject: UMLS:C0149473


subject: UMLS:C0149473


subject: PUBCHEM.COMPOUND:3367

object_name: Adult Classical Hodgkin Lymphoma


subject: CHEBI:63599

subject_name: Fludarabine


subject: UMLS:C1527241

subject_name: Recombinant Adenovirus-hIFN-beta

object_name: cancer


subject: UMLS:C1527241

object_name: neoplasm


subject: PUBCHEM.COMPOUND:9824461

subject_name: remimazolam

object_name: cerebrovascular disorder


subject: CHEBI:26537

subject_name: retinoid

object_name: psoriasis


subject: CHEBI:49668

subject_name: Gefitinib

object_name: Disseminated Malignant Neoplasm


subject: PUBCHEM.COMPOUND:156442379

object_name: Advanced cancer


subject: PUBCHEM.COMPOUND:156442379

object_name: Advanced Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:156442379


subject: PUBCHEM.COMPOUND:156442379


subject: UNII:F729CY2V48


subject: UNII:F729CY2V48


subject: UNII:F729CY2V48


subject: UNII:F729CY2V48


subject: UMLS:C5557243

subject_name: PD-L1 Inhibitor ABSK043

object_name: Solid Neoplasm


subject: UMLS:C5557243

object_name: non-small cell lung carcinoma


subject: UMLS:C5557243

object_name: urothelial carcinoma


subject: UMLS:C5557243

object_name: transitional cell carcinoma


subject: CHEBI:72690

subject_name: Pomalidomide

object_name: Human Immunodeficiency Virus 1 Positive


subject: CHEBI:232816

subject_name: fosmetpantotenate


subject: UNII:VA101M0K2F


subject: UMLS:C2828366

subject_name: Extract (substance)

object_name: osteoarthritis, knee


subject: CHEBI:87681

subject_name: Ranolazine

object_name: heart failure


subject: CHEBI:87681

object_name: Heart Failure, CTCAE


subject: CHEBI:58097

object_name: chronic post-procedural pain


subject: CHEBI:17303

subject_name: Morphine


subject: PR:000030954

subject_name: RNA-binding motif protein, Y chromosome, family 1 member A1

object_name: Complication of implant


subject: UniProtKB:O35698

subject_name: RBMY_MOUSE RNA-binding motif protein, Y chromosome (sprot)


subject: PR:000013814

subject_name: RNA-binding motif protein, Y chromosome, family 1 member B


subject: UNII:I99M8K8AXT

object_name: rheumatoid arthritis


subject: MESH:D000077203

subject_name: Sodium-Glucose Transporter 2 Inhibitors

object_name: Acute heart failure


subject: MESH:D000077203

object_name: Ventilator-associated lung injury


subject: UMLS:C3542461

subject_name: Sodium-Glucose Cotransporter 2 Inhibitor [EPC]


subject: UMLS:C3542461


subject: UMLS:C4733482

subject_name: Anti-BCMA Antibody-drug Conjugate AMG 224

object_name: plasma cell myeloma


subject: CHEBI:5109

subject_name: Fluocinonide

object_name: lupus cutaneous


subject: CHEBI:6715

subject_name: medroxyprogesterone

object_name: Endometrial Intraepithelial Neoplasia


subject: CHEBI:6715

object_name: atypical endometrial hyperplasia


subject: CHEBI:6715

object_name: Stage I Endometrial Carcinoma


subject: CHEBI:39548

subject_name: Atorvastatin


subject: CHEBI:39548


subject: CHEBI:39548


subject: CHEBI:25805

subject_name: oxygen atom

object_name: complete trisomy 21


subject: CHEBI:25805

object_name: Down syndrome


subject: CHEBI:15379

subject_name: Oxygen


subject: CHEBI:15379


subject: UMLS:C4765216

subject_name: YSPSL

object_name: liver disorder


subject: UMLS:C4765363

subject_name: rPSGL-Ig


subject: UMLS:C5666984

subject_name: Anti-B7-H4/ TOP1i Antibody-drug Conjugate AZD8205

object_name: Childhood Breast Carcinoma


subject: UMLS:C5666984

object_name: breast carcinoma


subject: UMLS:C5666984

object_name: breast cancer


subject: UMLS:C5666984

object_name: ovarian cancer


subject: UMLS:C5666984

object_name: ovarian neoplasm


subject: UMLS:C5666984

object_name: ovarian carcinoma


subject: UMLS:C5666984

object_name: non-small cell squamous lung carcinoma


subject: UMLS:C5666984

object_name: endometrial cancer


subject: UMLS:C5666984

object_name: uterine corpus cancer


subject: UMLS:C5666984

object_name: endometrial carcinoma


subject: UMLS:C5666984

object_name: carcinoma of biliary tract


subject: UMLS:C5706461

subject_name: Rilvegostomig


subject: UMLS:C5706461


subject: UMLS:C5706461


subject: UMLS:C5706461


subject: UNII:YSL2GUT2Q8

subject_name: RILVEGOSTOMIG


subject: UNII:YSL2GUT2Q8


subject: UNII:YSL2GUT2Q8


subject: UNII:YSL2GUT2Q8


subject: PUBCHEM.COMPOUND:155586901


subject: PUBCHEM.COMPOUND:155586901


subject: PUBCHEM.COMPOUND:155586901


subject: PUBCHEM.COMPOUND:155586901


subject: PUBCHEM.COMPOUND:155586901


subject: DRUGBANK:DB18982

subject_name: Saruparib


subject: DRUGBANK:DB18982


subject: DRUGBANK:DB18982


subject: DRUGBANK:DB18982


subject: DRUGBANK:DB18982


subject: PUBCHEM.COMPOUND:162524593


subject: PUBCHEM.COMPOUND:162524593


subject: PUBCHEM.COMPOUND:162524593


subject: PUBCHEM.COMPOUND:162524593


subject: PUBCHEM.COMPOUND:162524593


subject: UMLS:C5706468

subject_name: PARP1 Inhibitor AZD9574


subject: UMLS:C5706468


subject: UMLS:C5706468


subject: UMLS:C5706468


subject: UMLS:C5706468


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Diffuse large B-cell lymphoma, unclassifiable, NOS


subject: CHEBI:31355

object_name: Refractory Transformed B-Cell Non-Hodgkin Lymphoma


subject: CHEBI:31355

object_name: Recurrent Transformed B-Cell Non-Hodgkin Lymphoma


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:5864


subject: CHEBI:5864


subject: UNII:KG6VO684Z6

subject_name: Polatuzumab vedotin


subject: UNII:KG6VO684Z6


subject: UNII:KG6VO684Z6


subject: UMLS:C3641728


subject: UMLS:C3641728


subject: UMLS:C3641728


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: CHEBI:15552

subject_name: Epoprostenol

object_name: pulmonary hypertension, primary, 1


subject: CHEBI:15552

object_name: idiopathic pulmonary arterial hypertension


subject: CHEBI:15552

object_name: pulmonary arterial hypertension


subject: MESH:C000705476

object_name: leishmaniasis


subject: UNII:P050J5FWC5

subject_name: INTERFERON GAMMA

object_name: acute leukemia


subject: UNII:P050J5FWC5

object_name: Myelodysplasia


subject: UMLS:C3539881

subject_name: gamma-interferon


subject: UMLS:C3539881


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Surgical Complication


subject: PUBCHEM.COMPOUND:86821

object_name: metabolic dysfunction-associated steatotic liver disease


subject: PUBCHEM.COMPOUND:86821

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:86821

object_name: Insulin resistance


subject: PUBCHEM.COMPOUND:86821

object_name: Dyslipidemia


subject: PUBCHEM.COMPOUND:86821

object_name: Diabetes


subject: PUBCHEM.COMPOUND:86821

object_name: obesity due to melanocortin 4 receptor deficiency


subject: PUBCHEM.COMPOUND:86821

object_name: obesity


subject: PUBCHEM.COMPOUND:86821

object_name: Obesity, CTCAE


subject: PUBCHEM.COMPOUND:86821


subject: CHEBI:26125

subject_name: phytosterols


subject: CHEBI:26125


subject: CHEBI:26125


subject: CHEBI:26125


subject: CHEBI:26125


subject: CHEBI:26125


subject: CHEBI:26125


subject: CHEBI:26125


subject: CHEBI:26125


subject: PUBCHEM.COMPOUND:3367

object_name: Mantle cell lymphoma stage III


subject: PUBCHEM.COMPOUND:3367

object_name: Mantle cell lymphoma stage IV


subject: PUBCHEM.COMPOUND:3367

object_name: Adult Acute Lymphoblastic Leukemia in Remission


subject: PUBCHEM.COMPOUND:3367

object_name: Stage III Adult Diffuse Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:3367

object_name: Stage IV Adult Diffuse Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:3367

object_name: Chronic lymphocytic leukaemia stage 3


subject: PUBCHEM.COMPOUND:3367

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:3367

object_name: Chronic lymphocytic leukaemia stage 4


subject: PUBCHEM.COMPOUND:3367

object_name: Ann Arbor Stage III Grade 1 Follicular Lymphoma


subject: PUBCHEM.COMPOUND:3367

object_name: Ann Arbor Stage III Grade 3 Follicular Lymphoma


subject: PUBCHEM.COMPOUND:3367

object_name: Ann Arbor Stage III Grade 2 Follicular Lymphoma


subject: PUBCHEM.COMPOUND:3367

object_name: Ann Arbor Stage IV Grade 2 Follicular Lymphoma


subject: PUBCHEM.COMPOUND:3367

object_name: Ann Arbor Stage IV Grade 3 Follicular Lymphoma


subject: PUBCHEM.COMPOUND:3367

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: PUBCHEM.COMPOUND:3367

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: PUBCHEM.COMPOUND:3367

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: PUBCHEM.COMPOUND:3367

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: UMLS:C5556674

subject_name: pH Low Insertion Peptide-exatecan Conjugate CBX-12

object_name: Metastatic Malignant Solid Neoplasm


subject: UMLS:C5556674

object_name: Advanced Malignant Solid Neoplasm


subject: UNII:WC5YF463BE

object_name: Alzheimer disease type 1


subject: UNII:WC5YF463BE

object_name: Alzheimer disease


subject: DRUGBANK:DB19181


subject: DRUGBANK:DB19181


subject: UMLS:C1170000

subject_name: drotrecogin alfa

object_name: preeclampsia


subject: UNII:9AG41L3AOQ

subject_name: Gallium-68 PSMA

object_name: ovarian cancer


subject: UNII:9AG41L3AOQ

object_name: ovarian carcinoma


subject: UNII:9AG41L3AOQ

object_name: malignant epithelial tumor of ovary


subject: CHEBI:6504

object_name: drug mechanism


subject: CHEBI:40154


subject: UMLS:C4054033

subject_name: Suvemcitug


subject: UMLS:C5963535

subject_name: Antibody-drug Conjugate PHN-010


subject: UMLS:C5963535

object_name: Advanced cancer


subject: UMLS:C5963535

object_name: endometrial cancer


subject: UMLS:C5963535

object_name: uterine corpus cancer


subject: UMLS:C5963535

object_name: endometrial carcinoma


subject: UMLS:C5963535

object_name: cervical cancer


subject: UMLS:C5963535

object_name: cervical carcinoma


subject: UMLS:C5963535


subject: UMLS:C5963535

object_name: ovarian neoplasm


subject: UMLS:C5963535


subject: UMLS:C5963535

object_name: colon carcinoma


subject: UMLS:C5963535

object_name: colorectal cancer


subject: UMLS:C5963535

object_name: colon cancer


subject: UMLS:C5963535

object_name: lung cancer


subject: UMLS:C5963535

object_name: lung neoplasm


subject: UMLS:C5963535

object_name: lung carcinoma


subject: UMLS:C3896909

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:136924190

subject_name: Guadecitabine


subject: UNII:T1JP1KYU9O

subject_name: Flortaucipir F-18

object_name: traumatic encephalopathy


subject: UNII:T1JP1KYU9O

object_name: traumatic brain injury


subject: UNII:T1JP1KYU9O

object_name: Depressed mood


subject: UNII:T1JP1KYU9O

object_name: Cancer patients and suicide and depression


subject: UNII:T1JP1KYU9O

object_name: Depressed - symptom


subject: UNII:T1JP1KYU9O

object_name: Depression, CTCAE


subject: UMLS:C5564841

object_name: HIV-Associated Lipodystrophy Syndrome


subject: CHEBI:172944

subject_name: Cabotegravir


subject: UMLS:C0351302

subject_name: sodium salts


subject: CHEBI:26714

subject_name: sodium salt


subject: CHEBI:8382

subject_name: Prednisone

object_name: Postinfection inflammation


subject: CHEBI:8382

object_name: male infertility


subject: CHEBI:8382

object_name: inability to impregnate


subject: CHEBI:8382

object_name: Increased reactive oxygen species production


subject: CHEBI:8382

object_name: leukopenia


subject: CHEBI:2704

subject_name: Anastrozole

object_name: Dwarfism


subject: CHEBI:2704

object_name: Short stature


subject: CHEBI:2704

object_name: Short Stature, CTCAE


subject: CHEBI:6413

subject_name: Letrozole


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:73024

subject_name: O-acetylcarnitine

object_name: distal symmetric polyneuropathy


subject: CHEBI:73024

object_name: HIV infection


subject: CHEBI:57589

subject_name: Acetylcarnitine


subject: CHEBI:57589


subject: CHEBI:63626

subject_name: Tesamorelin

object_name: Body Composition


subject: CHEBI:63626


subject: CHEBI:63626

object_name: Congenital IGHD


subject: CHEBI:63626

object_name: Reduced circulating growth hormone concentration


subject: UMLS:C1313807


subject: UMLS:C1313807


subject: UMLS:C1313807


subject: UMLS:C1313807


subject: UMLS:C2745498

object_name: liver carcinoma


subject: UMLS:C1831836

subject_name: Melan-A VLP Vaccine

object_name: melanoma


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Platinum-Resistant Primary Peritoneal Carcinoma


subject: UNII:28X28X9OKV

object_name: Platinum-Resistant Fallopian Tube Carcinoma


subject: UNII:28X28X9OKV

object_name: Platinum-Resistant Ovarian Carcinoma


subject: UNII:28X28X9OKV

object_name: Refractory Ovarian Carcinoma


subject: UNII:28X28X9OKV

object_name: Refractory Primary Peritoneal Carcinoma


subject: UNII:28X28X9OKV

object_name: Refractory Fallopian Tube Carcinoma


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C2742586

subject_name: NXL 104

object_name: Complicated urinary tract infection


subject: CHEBI:85984

subject_name: Avibactam


subject: CHEBI:3509


subject: PUBCHEM.COMPOUND:6321415

subject_name: ceftazidime


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: Graft dysfunction


subject: CHEBI:61057

object_name: Graft failure


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: UMLS:C5666876

subject_name: BRAF V600E Inhibitor HLX208

object_name: thyroid gland undifferentiated (anaplastic) carcinoma


subject: UMLS:C5666876

object_name: ataxia telangiectasia